Company Overview
CN Healthy Food Tech Group Corp., together with its subsidiaries, engages in the research and development, production, and sale of bio-health food in the People's Republic of China. It operates through two segments, Wholesale Distribution and Live-Stream Sales. The company offers cordyceps peptide selenium powders, Baofei granule extract plant drinks, Yancui peptide selenium powders, Ganoderma lucidum and matsutake peptide selenium powders, ginseng peptide selenium powders, collagen peptide prebiotic drinks, plant essential oils, and Shangshangyi congee products. It sells its products through e-commerce and social platforms; and offline dealers. CN Healthy Food Tech Group Corp. was founded in 2024 and is based in Zhuhai, the People's Republic of China.
Why Investors Should Care
Generates a return on equity of 39.2%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 58.6%.
Maintains a net profit margin of 24.6%.
Carries low leverage with a debt-to-equity ratio of 0.17.
Recent Developments
- Dec 2025 Revenue of $27.76M (+144.6% YoY); net profit $8.41M.
- Trailing 12 Months Year-on-year growth — revenue +17.1%, earnings -4.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | 17.10% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -4.40% |
Stock Price Performance
| 1 Year: | -38.78% |
| 6 Months: | +0.00% |
| 3 Months: | +0.00% |
| 1 Month: | +0.00% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)28.00 · Oversold
P/E of 30.61 is above the sector median of 18.56 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 39.2%.
- Healthy ROCE of 58.6%.
- Excellent profit margin of 24.6%.
CONS
- Trading 55.9% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Consumer Defensive).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | UCFI CN Healthy Food Tech Group Corp. | 5.51 | 30.61 | $287.81M | 0.00% | 58.55% | 39.22% | - | - |
| 2 | WMT Walmart Inc. SPXR3K | 107.14 | 38.82 | $850.02B | 0.93% | 16.83% | 22.31% | 3.82% | 3.24% |
| 3 | COST Costco Wholesale Corporation NDXSPXR3K | 910.18 | 45.88 | $403.65B | 0.65% | 25.96% | 29.15% | 8.16% | 11.45% |
| 4 | KO The Coca-Cola Company SPXR3K | 88.36 | 26.53 | $380.17B | 2.41% | 16.47% | 42.05% | 2.86% | 4.46% |
| 5 | PG The Procter & Gamble Company SPXR3K | 145.58 | 21.99 | $338.39B | 2.95% | 22.49% | 30.29% | 0.52% | 1.59% |
| 6 | PM Philip Morris International Inc. SPXR3K | 184.73 | 25.37 | $287.92B | 3.09% | 34.03% | -113.55% | -1.69% | 3.57% |
| 7 | PEP PepsiCo, Inc. NDXSPXR3K | 138.45 | 18.15 | $189.12B | 4.43% | 15.41% | 51.51% | 4.93% | 2.11% |
| 8 | BUD Anheuser-Busch InBev SA/NV | 79.73 | 17.18 | $139.30B | 1.69% | 8.49% | 11.39% | 0.88% | 4.63% |
| 9 | BTI British American Tobacco p.l.c. | 55.15 | 14.18 | $118.73B | 5.98% | 12.44% | 13.42% | -2.53% | 5.21% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 4.29M | 6.09M | 4.82M | - | 7.91M | 7.88M | 5.83M |
| Cost of Revenue | - | - | - | - | - | - | 2.02M | 2.47M | - | 2.34M | 2.02M | 1.46M |
| Gross Profit | - | - | - | - | - | 2.95M | 4.08M | 2.36M | - | 5.57M | 5.85M | 4.36M |
| Operating Expenses | - | - | - | - | - | - | 1.21M | 1.55M | - | 983.47K | 3.33M | 3.63M |
| Operating Income | -104.53K | -60.32K | -137.13K | -479.86K | -238.41K | 2.30M | 2.87M | 805.20K | -671.53K | 4.58M | 2.52M | 730.62K |
| EBITDA | - | - | - | - | - | - | 2.95M | 983.17K | - | 4.58M | 2.71M | 938.16K |
| Interest Expense | - | - | - | - | - | - | - | 0 | - | - | - | 206.02K |
| Pretax Income | - | - | - | - | - | - | 2.92M | 898.79K | - | 4.72M | 2.67M | 541.54K |
| Tax Provision | - | - | - | - | - | - | 846.23K | 125.11K | - | 1.38M | 1.30M | 850.54K |
| Net Income | -104.53K | -60.32K | -137.13K | 375 | 356.84K | 1.57M | 2.07M | 773.68K | 2.92M | 3.34M | 1.37M | -309.00K |
| Diluted EPS | - | - | - | - | - | 0.04 | - | 0.02 | - | 0.07 | - | -0.01 |
| R&D Expense | - | - | - | - | - | - | - | 27.48K | - | 37.84K | - | 38.37K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | - | 0 | 11.35M | 27.76M |
| Cost of Revenue | - | 0 | 3.80M | 9.34M |
| Gross Profit | - | 0 | 7.54M | 18.42M |
| Operating Expenses | - | 0 | 2.00M | 6.64M |
| Operating Income | -181.00K | 0 | 5.54M | 11.78M |
| EBITDA | - | 0 | 5.74M | 12.39M |
| Interest Expense | - | - | - | - |
| Pretax Income | - | 0 | 5.61M | 12.32M |
| Tax Provision | - | 0 | 1.61M | 3.91M |
| Net Income | -181.00K | 0 | 4.00M | 8.41M |
| Diluted EPS | - | 0.00 | 0.08 | 0.17 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 671.67K | 15 | 50.75M | 44.73M |
| Current Assets | - | - | 15 | 44.02M | 36.89M |
| Cash & Equivalents | - | - | 15 | 41.43M | 33.01M |
| Inventory | - | - | 0 | 1.25M | 956.41K |
| Receivables | - | - | 0 | 845 | 287 |
| Total Liabilities | - | 847.04K | 14 | 39.94M | 24.85M |
| Current Liabilities | - | 847.04K | 14 | 39.94M | 24.61M |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | - | - | 0 | 3.95M |
| Total Equity | 5.63K | -175.37K | 1 | 10.81M | 19.87M |
| Shares Outstanding | - | - | 51.23M | 51.23M | 52.23M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Operating Cash Flow | 14 | 42.12M | -9.04M |
| Investing Cash Flow | 0 | -52.41K | -892.35K |
| Financing Cash Flow | 1 | 0 | 2.76K |
| Capital Expenditure | - | -52.41K | -753.25K |
| Free Cash Flow | 14 | 42.06M | -9.80M |
| Net Change in Cash | 15 | 42.06M | -9.93M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | - | - | 66.5% | 66.3% |
| Operating Margin % | - | - | 48.8% | 42.4% |
| Net Margin % | - | - | 35.2% | 30.3% |
| ROE % | 103.2% | 0.0% | 37.0% | 42.3% |
| ROCE % | 103.2% | 0.0% | 51.3% | 58.5% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | RiverNorth Capital Management, LLC | 0.19% | 101.51K | $559.30K |
| 2 | AQR Arbitrage LLC | 0.17% | 91.05K | $501.69K |
| 3 | Westchester Capital Management, LLC | 0.09% | 48.72K | $268.44K |
| 4 | Whitebox Advisors, LLC | 0.06% | 30.00K | $165.30K |
| 5 | Shaw D.E. & Co., Inc. | 0.05% | 23.81K | $131.18K |
| 6 | Yakira Capital Management, Inc. | 0.04% | 20.74K | $114.28K |
| 7 | Aristeia Capital, LLC | 0.03% | 16.84K | $92.79K |
| 8 | Geode Capital Management, LLC | 0.02% | 10.08K | $55.54K |
| 9 | Bulldog Investors, LLP | 0.02% | 10.92K | $60.16K |
| 10 | UBS Group AG | 0.01% | 3.94K | $21.69K |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for UCFI
Trading Halt Remains as CN Healthy Food Tech Plans Hearing Request - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxNcGFQbzl0SXBSQjBRdXN6WGh5WDVrazR6V2pVSHJDbVhsNGJsczlIWDNxcFNVNUVUd2wzNTd6Q3NuMFhGQkgxNmZHS0RNVFNGYlowMWlyZFFRTXlGTEd1ckRjZm5RT3BXcHpaWHdGdVYxQU12ZzhTUUJVd1hWV0V0RkdLblg0dVEwTFFweD…
CN Healthy Food Tech Group Corp. (NASDAQ: UCFI) Stock Price, News & Analysis - kalkine.com.au
<a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTE1lV3BfYVFzWDhKRjI1Q3ZJMDVUODR6aktGaGhuUkxITkpBTGRJb2lVMFI3SU5sZXVQTmJEdnlYcGh1X2tieXppSldHSHg5ZUtZWklOM1p3?oc=5" target="_blank">CN Healthy Food Tech Group Corp. (NASDAQ: UCFI) Sto…
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM - Bitget
<a href="https://news.google.com/rss/articles/CBMiY0FVX3lxTE03eWpRV0swSXBpaEpZTjg4UkRsdlNvNy1BS3RpUjl4UDVGZDRVSW1jaE40cnNVRzVzOWgtbDZYZTF3Vmx1WlZTRkkyX25rZ0U3MzNBX0E5bHh3YUVCM2RLdzY2ONIBY0FVX3lxTE03eWpRV0swSXBpaEpZTjg4UkRsdlNvNy1BS3RpUjl4UD…
CN Healthy Food Tech Group Received Notice of Delisting - tradingview.com
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxNbmxvZTVJaTJhcVYycFdxTDJYUTdvSE02cE1xU2ZCdnViYzlZQUdvN0NDdHgydG5wVE9IUi1PRS1oZWpCOEwzWkJXODg0eW9ZSWtSaW9GMVdtY3VFSzRNRXp5cHVFUTRXZVdnMjYxcjl3UElLbVBQOWNSSTlpY0U3T2pzY3pFa0VSMFFJak…
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE9ITGl4VjRXUldnWkR4ME9zNFhXZVpvMkpGblZZV1VpUEFWRi15WExDYUtXYWlhLTFmc291b2QySVc1MUxYNXFqTFk0LUFzaGVR?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
Iron Horse Acquisitions (UCFI) Stock Price, News & Analysis $UCFI - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTFBhSnBTUGxXb1JtbTNRdDZsVzBXdjI2ZXhqLVhfYWZPamp6WUFMT1RhLWZVTWtwdHBvU1FWTF9UckhHVlQwbmdxcERYM1dyZWxlLVRMOEp4US1BQQ?oc=5" target="_blank">Iron Horse Acquisitions (UCFI) Stock Price, N…
UCFI — Frequently Asked Questions
What is the current share price of CN Healthy Food Tech Group Corp. (UCFI)?
As of 2026-09-19 21:16 PDT, CN Healthy Food Tech Group Corp. (UCFI) trades at $5.51 on NasdaqCM. Its 52-week range is $4.09 to $12.50.
What is the market capitalisation of UCFI?
CN Healthy Food Tech Group Corp. (UCFI) has a market capitalisation of $287.81M on NasdaqCM.
What is the P/E ratio of UCFI?
UCFI trades at a trailing price-to-earnings (P/E) ratio of 30.61. The industry average P/E is 18.56. Its price-to-book (P/B) ratio is 14.46.
What is the return on equity (ROE) of UCFI?
UCFI has a return on equity (ROE) of 39.22%. Its return on capital employed (ROCE) is 58.55%.
Is UCFI a good stock to buy?
This page provides a data-driven analysis of CN Healthy Food Tech Group Corp. (UCFI), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.